2013
DOI: 10.5935/1518-0557.20130070
|View full text |Cite
|
Sign up to set email alerts
|

Comparison GnRH agonist short protocol and GnRH antagonist in Brazilian normoresponder patients undergoing their first cycle of controlled ovarian stimulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 24 publications
(45 reference statements)
0
2
0
Order By: Relevance
“…As demonstrated in this study, there is no difference in oocytes retrieval between these two protocols in recent meta analysis ( Tehraninejad et al , 2010 ; Bodri et al , 2011 ; Pu et al , 2011 ; Casano et al , 2012 ; Pundir et al , 2012 ) and randomized controlled trials ( Loutradis et al , 2004 ; Xavier et al , 2005 ; Kurzawa et al , 2008 ; Tazegul et al , 2008 ). Differently, some reports showed a less number of oocyte retrieval in the antagonist protocol ( Barmat et al , 2005 ; Arruda et al , 2013 ; Orvieto & Patrizio, 2013 ). Our results could be discussed in another way when we decide to use minor dose of gonadotropin.…”
Section: Discussionmentioning
confidence: 89%
See 1 more Smart Citation
“…As demonstrated in this study, there is no difference in oocytes retrieval between these two protocols in recent meta analysis ( Tehraninejad et al , 2010 ; Bodri et al , 2011 ; Pu et al , 2011 ; Casano et al , 2012 ; Pundir et al , 2012 ) and randomized controlled trials ( Loutradis et al , 2004 ; Xavier et al , 2005 ; Kurzawa et al , 2008 ; Tazegul et al , 2008 ). Differently, some reports showed a less number of oocyte retrieval in the antagonist protocol ( Barmat et al , 2005 ; Arruda et al , 2013 ; Orvieto & Patrizio, 2013 ). Our results could be discussed in another way when we decide to use minor dose of gonadotropin.…”
Section: Discussionmentioning
confidence: 89%
“…After corrected by age, our study shows a minor dose of uFSH in antagonist protocol, but with no significant difference when compared to agonist protocol. Some reports evidence that a less amount of uFSH is needed in antagonist protocol (Kurzawaa et al, 2008;Tazegul et al, 2008;Lainas et al, 2010;Tehraninejad et al, 2010;Pundir et al, 2012;Arruda et al, 2013) and other papers shows no difference between protocols (Barmat et al, 2005;Bodri et al, 2011). The small need of uFSH determine a more friendly stimulation with less risk of OHSS and a greater compliance of our patients in treatment.…”
Section: Discussionmentioning
confidence: 99%